CompletedPhase 1DMT

Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects

Sponsored by Beckley Psytech Limited

NCT ID
NCT05032833
Target Enrollment
36 participants
Start Date
2021-09-22
Est. Completion
2022-07-07

About This Study

The study will evaluate safety, tolerability and PK profile of 5-MeO-DMT in healthy subjects

Conditions Studied

Pharmacokinetics in Healthy Adults

Interventions

  • •5-MeO-DMT
  • •Placebo

Eligibility

Age:25 Years - 55 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

\* Medically healthy based on medical records and study specific assessments

Exclusion Criteria:

\* Presence or history of severe adverse reaction to any drug or drug excipient

Study Locations (1)

King's College London
London, United Kingdom

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects | Huxley